Literature DB >> 14754503

Involvement of protein kinase C-delta in DNA damage-induced apoptosis.

Alakananda Basu1.   

Abstract

Apoptosis is a highly orchestrated cell suicidal program required to maintain a balance between cell proliferation and cell death. A defect in apoptotic machinery can cause cancer. Many anticancer drugs are known to kill tumor cells by inducing apoptosis, and a defect in apoptosis can lead to anticancer drug resistance. Apoptosis is regulated by a complex cellular signaling network. Several members of the protein kinase C (PKC) family serve as substrates for caspases and PKCdelta isozyme has been intimately associated with DNA damage-induced apoptosis. It can act both upstream and downstream of caspases. In response to apoptotic stimuli, the full-length and the catalytic fragment of PKCdelta may translocate to distinct cellular compartments, including mitochondria and the nucleus, to reach their targets. Both activation and intracellular distribution of PKCdelta may have significant impact on apoptosis. This review intends to assimilate recent views regarding the involvement of PKCdelta in DNA damage-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14754503      PMCID: PMC6740315          DOI: 10.1111/j.1582-4934.2003.tb00237.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  33 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart.

Authors:  Xin Qi; Alice Vallentin; Eric Churchill; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2007-08-08       Impact factor: 5.000

3.  Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2.

Authors:  Alakananda Basu; Savitha Sridharan; Shalini Persaud
Journal:  Cell Signal       Date:  2009-07-23       Impact factor: 4.315

4.  PKCδ maintains phenotypes of tumor initiating cells through cytokine-mediated autocrine loop with positive feedback.

Authors:  R-K Kim; Y Suh; E Hwang; K-C Yoo; K-S Choi; S An; S-G Hwang; I-G Kim; M-J Kim; H-J Lee; S-J Lee
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

5.  Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity.

Authors:  Dongshan Zhang; Jian Pan; Xudong Xiang; Yu Liu; Guie Dong; Man J Livingston; Jian-Kang Chen; Xiao-Ming Yin; Zheng Dong
Journal:  J Am Soc Nephrol       Date:  2016-10-31       Impact factor: 10.121

6.  Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

Authors:  Elaine M Reno; James M Haughian; Irina K Dimitrova; Twila A Jackson; Kenneth R Shroyer; Andrew P Bradford
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

7.  Protein kinase Cdelta stimulates proteasome-dependent degradation of C/EBPalpha during apoptosis induction of leukemic cells.

Authors:  Meng Zhao; Xu-Fang Duan; Xu-Yun Zhao; Bo Zhang; Ying Lu; Wei Liu; Jin-Ke Cheng; Guo-Qiang Chen
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

8.  Regulation of HuR by DNA Damage Response Kinases.

Authors:  Hyeon Ho Kim; Kotb Abdelmohsen; Myriam Gorospe
Journal:  J Nucleic Acids       Date:  2010-07-25

9.  Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.

Authors:  Vivian R Ruvolo; Kul B Karanjeet; Todd F Schuster; Rhoderick Brown; Yibin Deng; Edward Hinchcliffe; Peter P Ruvolo
Journal:  J Signal Transduct       Date:  2010-01-01

10.  Sprouty2 interacts with protein kinase C delta and disrupts phosphorylation of protein kinase D1.

Authors:  Soah Yee Chow; Chye Yun Yu; Graeme R Guy
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.